Detecting Alzheimer’s Risks; Migraine and GI Disorders; CJD Glymphatic Dysfunction

Quantitative Alzheimer’s risk factors, including accelerated brain changes over time, were detectable in healthy individuals over age 50. (Nature Communications)

Traumatic brain injury was a risk factor linked with treatable incident neuropsychiatric and other medical conditions in subsequent years, a large study in California showed. (JAMA Network Open)

The ORCHESTRA proof-of-concept study of investigational minzasolmin for early Parkinson’s disease did not meet its primary and secondary clinical endpoints, UCB said.

Large-scale genetic studies showed that migraine shares genes with non-immune-related gastrointestinal disorders like irritable bowel syndrome. (Neurology Genetics)

In a randomized trial, transcutaneous auricular vagus nerve stimulation improved insomnia severity for people with chronic insomnia disorder. (JAMA Network Open)

Glymphatic dysfunction was linked with severity and progression of Creutzfeldt-Jakob disease (CJD) in a small study. (Neurology)

The ratio of plasma brain-derived tau to phosphorylated tau 217 improved CJD prognostication. (Alzheimer’s & Dementia)

Household smoking was linked with brain volumes in children with genetic risk for multiple sclerosis. (Journal of Neurology, Neurosurgery & Psychiatry)

Here’s how people with neurodegenerative diseases can cope with heat waves. (JAMA Neurology)

CMS issued a directive requiring Medicare Advantage plans to provide access to tofersen (Qalsody), a treatment for SOD1-amyotrophic lateral sclerosis (ALS) that received accelerated FDA approval, the ALS Association said.

What is the neurologist’s role in promoting brain health? (Neurology)

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow

Please enable JavaScript to view the

comments powered by Disqus.